<DOC>
	<DOCNO>NCT01111591</DOCNO>
	<brief_summary>In extrahepatic bile duct cancer pancreatic cancer , treat postoperatively COX2 inhibitor ass survival rate recurrent rate .</brief_summary>
	<brief_title>Cyclooxygenase-2 Inhibitor Adjuvant Anticancer Effect Patients With Biliary-pancreas Cancer</brief_title>
	<detailed_description>Patients : total 220 patient - Extrahepatic bile duct cancer : 55 patient administration COX2 55 patient control group - Pancreas cancer : 55 patient administration COX2 55 patient control group Indication - After operation extrahepatic bile duct cancer pancreas cancer - Age : 19 - 70 year old - The patient agree consent sheet . Contraindication - Impossible administration due severe postoperative morbidity ( bleed , bowel obstruction , pancreatic fistula , biliary fistula ) - Preexisting heart disease : Ischemic heart disease , Heart failure . Severe uncontrolled hypertension ( systolic BP &gt; 160 ) - Renal insufficiency : CCR &lt; 50 serum creatinin &gt; 3.0 - Hepatic insufficiency : Liver cirrhosis active hepatitis - Preexisting allergic reaction history NSAIDs Sulfonamide - Current drug intake : Warfarin . Lithium , Fluconazole , Aspirin , Celecoxib - Preexisting Asthma . Especially aspirin-sensitive asthma . - Contraindications aspirin , clopidogrel celecoxib - The patient refuse trial - The patient Psychogenic problem Allocation - We allocate patient randomly , administration group control group Methods - From postoperative third day , administration start - celecoxib 200mg bid 6 month administration group - Follow assess recurrence rate survival rate</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Bile Duct Neoplasms</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Cyclooxygenase 2 Inhibitors</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>The patient underwent operation extrahepatic bile duct cancer pancreas cancer Between 19 70 year old Agreed consent sheet The patient administration drug due severe postoperative morbidity . Preexisting heart disease : Ischemic heart disease , Heart failure . Severe uncontrolled hypertension ( systolic BP &gt; 160 ) Renal insufficiency : CCR &lt; 50 serum creatinin &gt; 3.0 Hepatic insufficiency : Liver cirrhosis active hepatitis Preexisting allergic reaction history NSAIDs Sulfonamide Current drug intake : Warfarin . Lithium , Fluconazole , Aspirin , Celecoxib Preexisting Asthma . Especially aspirinsensitive asthma . Contraindications aspirin , clopidogrel celecoxib When patient refuse Patients psychological problem</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Cyclooxygenase-2 inhibitor ( Celecoxib )</keyword>
	<keyword>Extrahepatic bile duct cancer</keyword>
	<keyword>Pancreas cancer</keyword>
</DOC>